PBM Capital Group Acquires Breas Medical

The acquisition of Breas will allow HDM to market the Z1 CPAP machine—a lightweight, portable ventilator which has become the fastest-growing sleep apnea device in the world—internationally, taking advantage of Breas Medical’s presence in more than 40 countries. Breas, on the other hand, will help PBM develop new products and enter the US market, a space it did not previously occupy.

“We acquired Breas because it is a logical fit with our growing HDM sleep apnea business,” said Paul B. Manning, CEO of PBM Capital. “The Z1 CPAP machine has had an incredible launch here in the United States, and we have more innovative products in the pipeline. The Breas acquisition opens the door to global distribution channels and gives us immediate access to an established line of home care ventilators backed by a strong IP portfolio. We are very excited to merge these two great companies.”

“The Breas management team is excited with this transaction and looks forward to leveraging our core efficient operation developed by GE Healthcare, our strong customer relationships, and significant global breadth with an entrepreneurial owner that is focused on changing the respiratory industry,” said Nicke Svanvik, CEO of Breas.

PBM Capital Group is a private investment firm focused on healthcare and life science investments across all stages of corporate development—venture capital, leveraged buyouts, growth capital, distressed/turnaround, and public equity value investing. Portfolio companies also include PBM Pharmaceuticals, Enzymatics, Triangle Research Labs, Firefly BioWorks, Gen 9, and QC Labs.

Related Links:
GE Healthcare
Breas Medical
PBM Capital Group